Virtual screening assisted identification of a phytocompound as potent inhibitor against Candida lusitaniae; an in-silico study

Abstract Candida lusitaniae is one of the fungal species which causes serious health illnesses including peritonitis, vaginitis and fungemia, among others. Several antifungal drugs have been designed to tackle its infections but their efficacy is still questionable due to their associated side effec...

Full description

Saved in:
Bibliographic Details
Main Authors: Rimsha Timotheous, Habiba Naz, Usman Arif, Momna Toqeer Dar, Muhammad Farhan Sarwar, Mudassar Fareed Awan, Sajed Ali, Safia Obaidur Rab
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Infectious Diseases
Subjects:
Online Access:https://doi.org/10.1186/s12879-024-10400-5
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841545018776485888
author Rimsha Timotheous
Habiba Naz
Usman Arif
Momna Toqeer Dar
Muhammad Farhan Sarwar
Mudassar Fareed Awan
Sajed Ali
Safia Obaidur Rab
author_facet Rimsha Timotheous
Habiba Naz
Usman Arif
Momna Toqeer Dar
Muhammad Farhan Sarwar
Mudassar Fareed Awan
Sajed Ali
Safia Obaidur Rab
author_sort Rimsha Timotheous
collection DOAJ
description Abstract Candida lusitaniae is one of the fungal species which causes serious health illnesses including peritonitis, vaginitis and fungemia, among others. Several antifungal drugs have been designed to tackle its infections but their efficacy is still questionable due to their associated side effects. Hence, there is a need to design those drugs which possess comparatively higher degree of therapeutic potential. Phytochemicals were selected in this regard because these compounds which satisfactorily follow this criteria as, their therapeutic index is comparatively larger than the synthetic drugs. Considering this fact, different phyto-compounds were opted in this research work to estimate their therapeutic efficiency against the secreted aspartyl proteinase (SAP) of C. lusitaniae since, it assists this pathogen in developing the infections. Initially, the structure of SAP was modelled for subsequent docking analysis. The results of molecular docking suggested that three compounds, opelconazole, daidzin 4'0-glucuronide and naringin exhibited better docking scores. Afterwards, ADME analysis of all these four compounds was performed to comprehend their drug-likeness attributes. The results of ADME analysis revealed that only the daidzin 4'0-glucuronide followed all the required parameters. Lastly, MD simulations were conducted in which top three compounds in context of docking scores along three approved anti-fungal drugs in complex with SAP were incorporated for the comparative analysis. The overall results of MD simulations suggested that daidzin 4'0-glucuronide exhibited comparatively better results. This outcome indicated that this particular compound not only showed better binding affinity with SAP during docking analysis and fulfilled all of the drug-likeness moieties among other compounds but also, displayed better simulation results, leading to a conclusion that daidzin 4'0-glucuronide could be a potential drug candidate against C. lusitaniae. However, its real-time efficacy could only be validated in clinical settings.
format Article
id doaj-art-fc369ea640624ff09375bece36ae10c4
institution Kabale University
issn 1471-2334
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj-art-fc369ea640624ff09375bece36ae10c42025-01-12T12:09:43ZengBMCBMC Infectious Diseases1471-23342025-01-0125112510.1186/s12879-024-10400-5Virtual screening assisted identification of a phytocompound as potent inhibitor against Candida lusitaniae; an in-silico studyRimsha Timotheous0Habiba Naz1Usman Arif2Momna Toqeer Dar3Muhammad Farhan Sarwar4Mudassar Fareed Awan5Sajed Ali6Safia Obaidur Rab7Department of Biotechnology, Knowledge Unit of Science (KUSC), University of Management and Technology (UMT) Sialkot CampusDepartment of Biotechnology, Knowledge Unit of Science (KUSC), University of Management and Technology (UMT) Sialkot CampusCentre of Excellence in Molecular Biology, University of the PunjabDepartment of Biotechnology, Knowledge Unit of Science (KUSC), University of Management and Technology (UMT) Sialkot CampusDepartment of Biotechnology, Knowledge Unit of Science (KUSC), University of Management and Technology (UMT) Sialkot CampusDepartment of Biotechnology, Knowledge Unit of Science (KUSC), University of Management and Technology (UMT) Sialkot CampusDepartment of Biotechnology, Knowledge Unit of Science (KUSC), University of Management and Technology (UMT) Sialkot CampusDepartment of Clinical Laboratory Sciences, College of Applied Medical Science, King Khalid UniversityAbstract Candida lusitaniae is one of the fungal species which causes serious health illnesses including peritonitis, vaginitis and fungemia, among others. Several antifungal drugs have been designed to tackle its infections but their efficacy is still questionable due to their associated side effects. Hence, there is a need to design those drugs which possess comparatively higher degree of therapeutic potential. Phytochemicals were selected in this regard because these compounds which satisfactorily follow this criteria as, their therapeutic index is comparatively larger than the synthetic drugs. Considering this fact, different phyto-compounds were opted in this research work to estimate their therapeutic efficiency against the secreted aspartyl proteinase (SAP) of C. lusitaniae since, it assists this pathogen in developing the infections. Initially, the structure of SAP was modelled for subsequent docking analysis. The results of molecular docking suggested that three compounds, opelconazole, daidzin 4'0-glucuronide and naringin exhibited better docking scores. Afterwards, ADME analysis of all these four compounds was performed to comprehend their drug-likeness attributes. The results of ADME analysis revealed that only the daidzin 4'0-glucuronide followed all the required parameters. Lastly, MD simulations were conducted in which top three compounds in context of docking scores along three approved anti-fungal drugs in complex with SAP were incorporated for the comparative analysis. The overall results of MD simulations suggested that daidzin 4'0-glucuronide exhibited comparatively better results. This outcome indicated that this particular compound not only showed better binding affinity with SAP during docking analysis and fulfilled all of the drug-likeness moieties among other compounds but also, displayed better simulation results, leading to a conclusion that daidzin 4'0-glucuronide could be a potential drug candidate against C. lusitaniae. However, its real-time efficacy could only be validated in clinical settings.https://doi.org/10.1186/s12879-024-10400-5C. lusitaniaeMolecular docking analysisPhytochemicalsSecreted aspartyl proteinase (SAP)Virtual screening
spellingShingle Rimsha Timotheous
Habiba Naz
Usman Arif
Momna Toqeer Dar
Muhammad Farhan Sarwar
Mudassar Fareed Awan
Sajed Ali
Safia Obaidur Rab
Virtual screening assisted identification of a phytocompound as potent inhibitor against Candida lusitaniae; an in-silico study
BMC Infectious Diseases
C. lusitaniae
Molecular docking analysis
Phytochemicals
Secreted aspartyl proteinase (SAP)
Virtual screening
title Virtual screening assisted identification of a phytocompound as potent inhibitor against Candida lusitaniae; an in-silico study
title_full Virtual screening assisted identification of a phytocompound as potent inhibitor against Candida lusitaniae; an in-silico study
title_fullStr Virtual screening assisted identification of a phytocompound as potent inhibitor against Candida lusitaniae; an in-silico study
title_full_unstemmed Virtual screening assisted identification of a phytocompound as potent inhibitor against Candida lusitaniae; an in-silico study
title_short Virtual screening assisted identification of a phytocompound as potent inhibitor against Candida lusitaniae; an in-silico study
title_sort virtual screening assisted identification of a phytocompound as potent inhibitor against candida lusitaniae an in silico study
topic C. lusitaniae
Molecular docking analysis
Phytochemicals
Secreted aspartyl proteinase (SAP)
Virtual screening
url https://doi.org/10.1186/s12879-024-10400-5
work_keys_str_mv AT rimshatimotheous virtualscreeningassistedidentificationofaphytocompoundaspotentinhibitoragainstcandidalusitaniaeaninsilicostudy
AT habibanaz virtualscreeningassistedidentificationofaphytocompoundaspotentinhibitoragainstcandidalusitaniaeaninsilicostudy
AT usmanarif virtualscreeningassistedidentificationofaphytocompoundaspotentinhibitoragainstcandidalusitaniaeaninsilicostudy
AT momnatoqeerdar virtualscreeningassistedidentificationofaphytocompoundaspotentinhibitoragainstcandidalusitaniaeaninsilicostudy
AT muhammadfarhansarwar virtualscreeningassistedidentificationofaphytocompoundaspotentinhibitoragainstcandidalusitaniaeaninsilicostudy
AT mudassarfareedawan virtualscreeningassistedidentificationofaphytocompoundaspotentinhibitoragainstcandidalusitaniaeaninsilicostudy
AT sajedali virtualscreeningassistedidentificationofaphytocompoundaspotentinhibitoragainstcandidalusitaniaeaninsilicostudy
AT safiaobaidurrab virtualscreeningassistedidentificationofaphytocompoundaspotentinhibitoragainstcandidalusitaniaeaninsilicostudy